PL3459542T3 - Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego - Google Patents
Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnegoInfo
- Publication number
- PL3459542T3 PL3459542T3 PL17799674T PL17799674T PL3459542T3 PL 3459542 T3 PL3459542 T3 PL 3459542T3 PL 17799674 T PL17799674 T PL 17799674T PL 17799674 T PL17799674 T PL 17799674T PL 3459542 T3 PL3459542 T3 PL 3459542T3
- Authority
- PL
- Poland
- Prior art keywords
- trippersal
- neuralgy
- carbaminate
- prevention
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061386 | 2016-05-19 | ||
| PCT/KR2017/005172 WO2017200317A1 (ko) | 2016-05-19 | 2017-05-18 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| EP17799674.1A EP3459542B1 (en) | 2016-05-19 | 2017-05-18 | Use of carbamate compound for preventing or treating trigeminal neuralgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3459542T3 true PL3459542T3 (pl) | 2021-12-27 |
Family
ID=60325324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17799674T PL3459542T3 (pl) | 2016-05-19 | 2017-05-18 | Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11207295B2 (pl) |
| EP (1) | EP3459542B1 (pl) |
| JP (1) | JP6960415B2 (pl) |
| KR (1) | KR102421013B1 (pl) |
| CN (1) | CN109310669B (pl) |
| AU (1) | AU2017267160B2 (pl) |
| CA (1) | CA3024284C (pl) |
| DK (1) | DK3459542T3 (pl) |
| ES (1) | ES2887338T3 (pl) |
| MX (1) | MX389613B (pl) |
| PL (1) | PL3459542T3 (pl) |
| PT (1) | PT3459542T (pl) |
| RU (1) | RU2751504C2 (pl) |
| WO (1) | WO2017200317A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3556365B1 (en) * | 2016-12-14 | 2025-07-02 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease |
| MX2021003203A (es) * | 2018-09-21 | 2021-05-27 | Sk Biopharmaceuticals Co Ltd | Compuesto de carbamato y uso de la formulacion que comprende el mismo en prevenir, aliviar, o tratar trastorno de estres agudo o trastorno de estres post-traumatico. |
| JP7369185B2 (ja) * | 2018-10-19 | 2023-10-25 | エスケー バイオファーマスティカルズ カンパニー リミテッド | カルバメート化合物の糖尿病性末梢神経障害又は化学療法剤誘発性末梢神経障害の予防、緩和又は治療のための使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| EP0959882A4 (en) * | 1996-12-31 | 2001-12-05 | N-BONDED UREAUTIES AND CARBAMATES OF HETEROCYCLIC THIOESTERS | |
| US6815464B2 (en) * | 2001-02-27 | 2004-11-09 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in the treatment of pain |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP4227121B2 (ja) | 2005-06-08 | 2009-02-18 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| BRPI0924997B1 (pt) * | 2009-06-22 | 2024-01-16 | Sk Biopharmaceuticals Co., Ltd | Método para preparar um composto de éster do ácido 1-aril-2- tetrazoil etil carbâmico |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| KR20140009244A (ko) * | 2010-11-11 | 2014-01-22 | 애크런 몰레큘스 게엠베하 | 통증 치료용 화합물 및 방법 |
| KR102232198B1 (ko) | 2014-05-09 | 2021-03-26 | 테크니메데 소시에다데 테크니코-메디시날 에스.에이. | 의약으로서 사용되기 위한 (r)-펄린돌 및 약학적으로 허용 가능한 그의 염 |
-
2017
- 2017-05-16 KR KR1020170060713A patent/KR102421013B1/ko active Active
- 2017-05-18 PL PL17799674T patent/PL3459542T3/pl unknown
- 2017-05-18 RU RU2018144784A patent/RU2751504C2/ru active
- 2017-05-18 ES ES17799674T patent/ES2887338T3/es active Active
- 2017-05-18 US US16/302,860 patent/US11207295B2/en active Active
- 2017-05-18 DK DK17799674.1T patent/DK3459542T3/da active
- 2017-05-18 JP JP2018560617A patent/JP6960415B2/ja active Active
- 2017-05-18 AU AU2017267160A patent/AU2017267160B2/en active Active
- 2017-05-18 CN CN201780030912.5A patent/CN109310669B/zh active Active
- 2017-05-18 MX MX2018014081A patent/MX389613B/es unknown
- 2017-05-18 CA CA3024284A patent/CA3024284C/en active Active
- 2017-05-18 PT PT177996741T patent/PT3459542T/pt unknown
- 2017-05-18 WO PCT/KR2017/005172 patent/WO2017200317A1/ko not_active Ceased
- 2017-05-18 EP EP17799674.1A patent/EP3459542B1/en active Active
-
2021
- 2021-12-02 US US17/457,308 patent/US12611395B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT3459542T (pt) | 2021-08-24 |
| EP3459542B1 (en) | 2021-06-30 |
| US20190175555A1 (en) | 2019-06-13 |
| EP3459542A1 (en) | 2019-03-27 |
| RU2018144784A (ru) | 2020-06-19 |
| RU2751504C2 (ru) | 2021-07-14 |
| CN109310669B (zh) | 2022-02-22 |
| MX389613B (es) | 2025-03-20 |
| BR112018073556A2 (pt) | 2019-03-19 |
| CA3024284A1 (en) | 2017-11-23 |
| MX2018014081A (es) | 2019-09-02 |
| JP6960415B2 (ja) | 2021-11-05 |
| EP3459542A4 (en) | 2020-01-08 |
| US20220087976A1 (en) | 2022-03-24 |
| KR102421013B1 (ko) | 2022-07-14 |
| ES2887338T3 (es) | 2021-12-22 |
| KR20170131241A (ko) | 2017-11-29 |
| AU2017267160A1 (en) | 2018-12-13 |
| WO2017200317A1 (ko) | 2017-11-23 |
| JP2019516722A (ja) | 2019-06-20 |
| CN109310669A (zh) | 2019-02-05 |
| DK3459542T3 (da) | 2021-09-13 |
| RU2018144784A3 (pl) | 2020-08-11 |
| US11207295B2 (en) | 2021-12-28 |
| US12611395B2 (en) | 2026-04-28 |
| CA3024284C (en) | 2024-01-23 |
| AU2017267160B2 (en) | 2022-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2025027I1 (el) | Ελαφιμπρανορη για χρηση στην αντιμετωπιση πρωτοπαθους χολικης χολαγγειiτιδας | |
| IL269354A (en) | Compounds useful in the treatment or prevention of a prmt5-mediated disorder | |
| HUE060078T2 (hu) | CDK7 gátlására alkalmas vegyületek | |
| PT3504187T (pt) | Utilização da pridopidina no tratamento do declínio funcional | |
| EP4212536C0 (en) | BENZOXAZEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | |
| HUE049591T2 (hu) | Makrociklusos MCL-1 inhibitorok rák kezelésére | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| DK3347030T3 (da) | Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme | |
| HUE056287T2 (hu) | Pancreatitis kezelése | |
| IL268694A (en) | Treatment of schizophrenia | |
| PL3377516T3 (pl) | Kompozycja do leczenia nowotworu | |
| HUE055263T2 (hu) | 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| PL3504214T3 (pl) | Skondensowane trójpierścieniowe związki pirydazynonowe przydatne w leczeniu infekcji ortomyksowirusami | |
| IL255185A0 (en) | 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| DK3331610T3 (da) | Midler til anvendelse til behandling af gliom | |
| DK3191103T3 (da) | Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner | |
| LT3307267T (lt) | Išsėtinės sklerozės gydymas | |
| DK3220952T3 (da) | Fremgangsmåde til behandling eller forebyggelse af slagtilfælde | |
| EP3484854A4 (en) | APOPTOSIS INHIBITORS | |
| PL3113778T3 (pl) | Pochodne pirydazyny do stosowania w zapobieganiu lub leczeniu zaburzenia ataktycznego | |
| PL3297625T3 (pl) | Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek | |
| IL256111B1 (en) | Pac–1 combination therapy | |
| DK3286317T3 (da) | Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi |